Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activation

Mark Barok, Maija Puhka, Gyorgy Vereb, Janos Szollosi, Jorma Isola, Heikki Joensuu

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number504
JournalBMC Cancer
Volume18
Number of pages12
ISSN1471-2407
DOIs
Publication statusPublished - 2 May 2018
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Breast cancer
  • Trastuzumab-emtansine
  • T-DM1
  • HER2
  • Exosome
  • BREAST-CANCER
  • MICROVESICLES
  • BIOGENESIS
  • MEDIATORS
  • DELIVERY
  • THERAPY
  • 3122 Cancers

Cite this